Publicaciones en colaboración con investigadores/as de Instituto de Neurociencias de Castilla y León (8)

2021

  1. Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))

    EBioMedicine

2020

  1. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo

    Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504

  2. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283

    EBioMedicine, Vol. 62

2017

  1. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK

    Stem Cell Reports, Vol. 9, Núm. 2, pp. 451-463

  2. A c-Src inhibitor peptide based on connexin43 exerts neuroprotective effects through the inhibition of glial hemichannel activity

    Frontiers in Molecular Neuroscience, Vol. 10

  3. Biotinylated cell-penetrating peptides to study intracellular protein-protein interactions

    Journal of Visualized Experiments, Vol. 2017, Núm. 130

2016

  1. Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

    Oncotarget, Vol. 7, Núm. 31, pp. 49819-49833

  2. The role of connexin43-Src interaction in astrocytomas: A molecular puzzle

    Neuroscience, Vol. 323, pp. 183-194